Tuberculosis drug causes “power failure” in ultra-fit cancer cells

Good News Notes: “Leveraging a newfound ability to identify the “fittest” metastatic cancer cells, scientists at the UK’s University of Salford have discovered that an already approved drug can be deployed to cut off their fuel supply, while leaving normal healthy cells unharmed. Metastatic cancer cells are dangerous, fast-moving cells cancer cells that have spread…

FDA Approves First Therapy for Patients with Lung and Thyroid Cancers with a Certain Genetic Mutation or Fusion

 Good News Notes: “Today, the U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors – non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers – in patients whose tumors have an alteration (mutation or fusion) in a specific gene (RET or “rearranged during transfection”). Retevmo…